Spire Healthcare Group (LON:SPI)‘s stock had its “hold” rating reaffirmed by equities research analysts at Peel Hunt in a research note issued to investors on Monday. They currently have a GBX 175 ($2.28) price objective on the stock, down from their previous price objective of GBX 278 ($3.62). Peel Hunt’s target price points to a potential upside of 14.38% from the company’s previous close.

SPI has been the topic of a number of other reports. JPMorgan Chase & Co. dropped their target price on Spire Healthcare Group from GBX 293 ($3.82) to GBX 256 ($3.33) and set a “neutral” rating on the stock in a research report on Tuesday, August 7th. Berenberg Bank reaffirmed a “sell” rating and set a GBX 120 ($1.56) target price on shares of Spire Healthcare Group in a research report on Tuesday, September 18th. Credit Suisse Group raised Spire Healthcare Group to a “neutral” rating and dropped their target price for the stock from GBX 250 ($3.26) to GBX 215 ($2.80) in a research report on Wednesday, August 8th. Liberum Capital reaffirmed a “hold” rating on shares of Spire Healthcare Group in a research report on Friday, August 24th. Finally, Jefferies Financial Group lowered Spire Healthcare Group to a “hold” rating and dropped their target price for the stock from GBX 290 ($3.78) to GBX 160 ($2.08) in a research report on Friday, August 10th. One research analyst has rated the stock with a sell rating, six have given a hold rating and one has given a buy rating to the company. Spire Healthcare Group has a consensus rating of “Hold” and a consensus price target of GBX 204.63 ($2.67).

Shares of LON SPI opened at GBX 153 ($1.99) on Monday. Spire Healthcare Group has a 1 year low of GBX 206.40 ($2.69) and a 1 year high of GBX 362.10 ($4.72).

In other news, insider Adèle Anderson acquired 9,582 shares of the stock in a transaction that occurred on Friday, September 21st. The stock was purchased at an average cost of GBX 155 ($2.02) per share, with a total value of £14,852.10 ($19,346.23). Also, insider Peter R. Bamford acquired 10,000 shares of the stock in a transaction that occurred on Thursday, August 9th. The stock was purchased at an average cost of GBX 161 ($2.10) per share, with a total value of £16,100 ($20,971.73).

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

Recommended Story: What is the S&P 500 Index?

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.